0001127602-19-017340.txt : 20190503
0001127602-19-017340.hdr.sgml : 20190503
20190503174706
ACCESSION NUMBER: 0001127602-19-017340
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190501
FILED AS OF DATE: 20190503
DATE AS OF CHANGE: 20190503
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnston Lori A
CENTRAL INDEX KEY: 0001558616
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37702
FILM NUMBER: 19797472
MAIL ADDRESS:
STREET 1: C/O CELANESE CORPORATION
STREET 2: 222 W. LAS COLINAS BLVD., SUITE 900N
CITY: IRVING
STATE: TX
ZIP: 75039
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-05-01
0000318154
AMGEN INC
AMGN
0001558616
Johnston Lori A
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
SVP, HR
Common Stock
2019-05-01
4
F
0
341
179.3232
D
16505
D
These share include the following RSUs granted under the Company's equity plans: 2,398 RSUs which vest in two equal installments of 1,199 on 2/7/2020 and 2/7/2021, respectively; 1,319 RSUs which vest in installments of 649 5/1/2020 and 670 on 5/1/2021; and 2,028 RSUs which vest in three installments of 669 on 4/27/2020, 669 on 4/27/2021 and 690 on 4/27/2022. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 288 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
/s/ Lori A. Johnston
2019-05-02